Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals drives innovation in cholestatic liver disease therapy, boasting a $5.94B market cap and Nasdaq presence while investing heavily in R&D to improve patient outcomes.

Mirum Pharmaceuticals Inc. is a pioneering company focused on developing therapies for cholestatic liver diseases, showcasing innovation and resilience in the pharmaceutical industry.